Group One Trading’s Tenaya Therapeutics TNYA Stock Holding History

Group One Trading’s Portfolio TNYA Stock Details TNYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5,200	Closed	-$3.7K	–	8762
2025 Q4	$3.7K	Buy	+5,200	New	+$7.07K	﹤0.01%	7314
2025 Q3	–	Sell	-10,000	Closed	-$6.11K	–	9161
2025 Q2	$6.11K	Sell	10,000 -7,100	-42%	-$3.61K	﹤0.01%	6999
2025 Q1	$9.75K	Buy	17,100 +100	+0.6%	+$99	﹤0.01%	6282
2024 Q4	$24.3K	Buy	+17,000	New	+$38.1K	﹤0.01%	5566
2024 Q1	–	Sell	-300	Closed	-$972	–	7972
2023 Q4	$972	Hold	300	–	–	﹤0.01%	6991
2023 Q3	$765	Hold	300	–	–	﹤0.01%	7267
2023 Q2	$1.76K	Buy	+300	New	+$1.74K	﹤0.01%	7121
2022 Q4	–	Sell	-23,200	Closed	-$67K	–	8095
2022 Q3	$67K	Buy	+23,200	New	+$108K	﹤0.01%	5152

Other funds holding TNYA

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

EAM

Empery Asset Management New York $83M AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BGM

Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $141M AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Group One Trading's TNYA Position: Q1 2026 in Review

Group One Trading increased its Tenaya Therapeutics (TNYA) stake by 141% in Q1 2026, buying an estimated $9.93K and bringing the position to 22,961 shares worth $15.9K. The position accounts for ﹤0.01% of the portfolio, ranked #6101.

Group One Trading first reported a position in TNYA in Q3 2022 and has held it in 7 quarters since. The position peaked at $53K in Q3 2025. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

Group One Trading held 22,961 shares of Tenaya Therapeutics worth $15.9K as of Q1 2026.
Group One Trading bought 13,453 Tenaya Therapeutics shares in Q1 2026, an estimated $9.93K.
Tenaya Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #6101 holding.
Group One Trading first reported a position in Tenaya Therapeutics in Q3 2022 and has held it in 7 quarters since.
Group One Trading's Tenaya Therapeutics position peaked at $53K in Q3 2025.
103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.